Bio-Techne Corp (TECH)
71.88
-0.64
(-0.88%)
USD |
NASDAQ |
Mar 18, 16:00
71.88
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Total Assets (Quarterly): 2.731B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.731B |
September 30, 2023 | 2.755B |
June 30, 2023 | 2.639B |
March 31, 2023 | 2.600B |
December 31, 2022 | 2.363B |
September 30, 2022 | 2.351B |
June 30, 2022 | 2.295B |
March 31, 2022 | 2.300B |
December 31, 2021 | 2.305B |
September 30, 2021 | 2.270B |
June 30, 2021 | 2.263B |
March 31, 2021 | 2.085B |
December 31, 2020 | 2.068B |
September 30, 2020 | 2.053B |
June 30, 2020 | 2.028B |
March 31, 2020 | 1.999B |
December 31, 2019 | 1.998B |
September 30, 2019 | 1.925B |
June 30, 2019 | 1.884B |
March 31, 2019 | 1.873B |
December 31, 2018 | 1.845B |
September 30, 2018 | 1.872B |
June 30, 2018 | 1.593B |
March 31, 2018 | 1.618B |
December 31, 2017 | 1.555B |
Date | Value |
---|---|
September 30, 2017 | 1.527B |
June 30, 2017 | 1.558B |
March 31, 2017 | 1.533B |
December 31, 2016 | 1.520B |
September 30, 2016 | 1.517B |
June 30, 2016 | 1.130B |
March 31, 2016 | 1.122B |
December 31, 2015 | 1.133B |
September 30, 2015 | 1.128B |
June 30, 2015 | 1.063B |
March 31, 2015 | 1.104B |
December 31, 2014 | 1.119B |
September 30, 2014 | 1.018B |
June 30, 2014 | 862.49M |
March 31, 2014 | 830.57M |
December 31, 2013 | 802.16M |
September 30, 2013 | 779.29M |
June 30, 2013 | 778.10M |
March 31, 2013 | 760.29M |
December 31, 2012 | 724.57M |
September 30, 2012 | 712.63M |
June 30, 2012 | 719.32M |
March 31, 2012 | 684.03M |
December 31, 2011 | 624.25M |
September 30, 2011 | 628.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.873B
Minimum
Mar 2019
2.755B
Maximum
Sep 2023
2.239B
Average
2.267B
Median
Total Assets (Quarterly) Benchmarks
Agilent Technologies Inc | 10.95B |
Revvity Inc | 13.56B |
Twist Bioscience Corp | 732.82M |
AIM ImmunoTech Inc | 27.86M |
Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 767.19M |
Shareholders Equity (Quarterly) | 1.964B |
Debt to Equity Ratio | 0.2276 |
Current Ratio | 4.368 |
Net Debt Paydown Yield | -0.30% |